Latest

Aug 13, 2026, 13:11 Srini Pallia Has More Large Deals at Wipro. He Still Needs a Growth Model That Pays

Aug 12, 2026, 15:05 Mitsuko Tottori Must Make Japan Airlines Safer and Less Dependent on the Airline Cycle

Aug 11, 2026, 13:27 Shuntaro Furukawa Won the Switch 2 Launch. The Second Year Will Define Its Economics

Aug 10, 2026, 17:04 Nithin Kamath Built Zerodha for a Boom. Regulation Is Testing the Model in Reverse

Aug 09, 2026, 10:46 Ravi Kumar S Has Restarted Cognizant’s Growth. The AI Builder Strategy Must Now Deepen It

Aug 08, 2026, 18:14 Noubar Afeyan’s Venture Factory Faces the Test That Matters: Translation

Aug 07, 2026, 16:25 Assaf Rappaport Sold Wiz to Google. Now He Must Prove Independence Can Survive Integration

Aug 06, 2026, 18:49 Tony Fernandes Finally Has a Clean Capital A. Now He Must Prove What Remains Is a Business

Noubar Afeyan

Noubar Afeyan, founder and chief executive officer of Flagship Pioneering

Noubar Afeyan’s Venture Factory Faces the Test That Matters: Translation

Flagship Pioneering enters 2026 with $14 billion under direction and fresh companies spanning modified DNA, AI and agriculture. The harder challenge is converting breadth into repeatable clinical and commercial evidence.

Noubar Afeyan, co-founder and Chairman of Moderna

Noubar Afeyan Oversaw Moderna’s $2.2 Billion Cost Reset. The Cash Runway Is the Board’s Next Test

Noubar Afeyan’s most consequential job in 2026 is chairing Moderna through a costly transition. The board has backed deep savings and a tighter pipeline; its next obligation is to show that lower spending can produce durable medicines before cash declines too far.